SG Americas Securities
TELA icon

SG Americas Securities’s TELA Bio TELA Stock Holding History

SG Americas Securities’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,769
Closed -$16K – 3578
2025
Q1 		$16K Buy
+12,769
New +$31.4K ﹤0.01% 3393

Other funds holding TELA

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

SG Americas Securities's TELA Position: Q2 2025 in Review

SG Americas Securities sold out of TELA Bio (TELA) in Q2 2025, closing a stake of 12,769 shares — an estimated $16K sold.

SG Americas Securities first reported a position in TELA in Q1 2025 and held it in 1 quarter. The position peaked at $16K in Q1 2025. 46 funds tracked by Wall St. Rank hold TELA as of Q2 2025.

  • SG Americas Securities reported no remaining TELA Bio position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 12,769 TELA Bio shares in Q2 2025, an estimated $16K.
  • SG Americas Securities first reported a position in TELA Bio in Q1 2025 and held it in 1 quarter.
  • SG Americas Securities's TELA Bio position peaked at $16K in Q1 2025.
  • 46 funds tracked by Wall St. Rank held TELA Bio as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.